Wells Fargo’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $232K | Buy |
33,748
+3,228
| +11% | +$22.2K | ﹤0.01% | 4301 |
|
|
2025
Q1 | $87.9K | Sell |
30,520
-3,744
| -11% | -$10.8K | ﹤0.01% | 4717 |
|
|
2024
Q4 | $161K | Buy |
34,264
+8,761
| +34% | +$41.2K | ﹤0.01% | 4433 |
|
|
2024
Q3 | $91K | Buy |
25,503
+383
| +2% | +$1.37K | ﹤0.01% | 4677 |
|
|
2024
Q2 | $156K | Buy |
25,120
+24,733
| +6,391% | +$153K | ﹤0.01% | 4316 |
|
|
2024
Q1 | $3.65K | Buy |
387
+6
| +2% | +$57 | ﹤0.01% | 5550 |
|
|
2023
Q4 | $2.57K | Buy |
381
+20
| +6% | +$135 | ﹤0.01% | 5618 |
|
|
2023
Q3 | $1.6K | Sell |
361
-604
| -63% | -$2.68K | ﹤0.01% | 5751 |
|
|
2023
Q2 | $3.19K | Sell |
965
-8,801
| -90% | -$29K | ﹤0.01% | 5841 |
|
|
2023
Q1 | $27.8K | Buy |
9,766
+6,571
| +206% | +$18.7K | ﹤0.01% | 5181 |
|
|
2022
Q4 | $23.3K | Sell |
3,195
-2,358
| -42% | -$17.2K | ﹤0.01% | 4879 |
|
|
2022
Q3 | $45K | Sell |
5,553
-317
| -5% | -$2.57K | ﹤0.01% | 4702 |
|
|
2022
Q2 | $29K | Sell |
5,870
-8,183
| -58% | -$40.4K | ﹤0.01% | 4990 |
|
|
2022
Q1 | $332K | Sell |
14,053
-8,765
| -38% | -$207K | ﹤0.01% | 4407 |
|
|
2021
Q4 | $403K | Buy |
22,818
+16,959
| +289% | +$300K | ﹤0.01% | 4506 |
|
|
2021
Q3 | $165K | Sell |
5,859
-2,073
| -26% | -$58.4K | ﹤0.01% | 4896 |
|
|
2021
Q2 | $83K | Sell |
7,932
-1,417
| -15% | -$14.8K | ﹤0.01% | 5054 |
|
|
2021
Q1 | $110K | Sell |
9,349
-9,483
| -50% | -$112K | ﹤0.01% | 5101 |
|
|
2020
Q4 | $221K | Buy |
18,832
+3,992
| +27% | +$46.8K | ﹤0.01% | 4903 |
|
|
2020
Q3 | $117K | Sell |
14,840
-458
| -3% | -$3.61K | ﹤0.01% | 5006 |
|
|
2020
Q2 | $279K | Buy |
15,298
+6,176
| +68% | +$113K | ﹤0.01% | 4557 |
|
|
2020
Q1 | $109K | Buy |
9,122
+7,129
| +358% | +$85.2K | ﹤0.01% | 4825 |
|
|
2019
Q4 | $33K | Buy |
1,993
+1,629
| +448% | +$27K | ﹤0.01% | 5348 |
|
|
2019
Q3 | $2K | Buy |
+364
| New | +$2K | ﹤0.01% | 5738 |
|